DK434488D0 - Heteroarylethere og heteroaromatiske n-oxider eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse - Google Patents

Heteroarylethere og heteroaromatiske n-oxider eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse

Info

Publication number
DK434488D0
DK434488D0 DK434488A DK434488A DK434488D0 DK 434488 D0 DK434488 D0 DK 434488D0 DK 434488 A DK434488 A DK 434488A DK 434488 A DK434488 A DK 434488A DK 434488 D0 DK434488 D0 DK 434488D0
Authority
DK
Denmark
Prior art keywords
heteroarylethers
heteroaromatic
oxides
preparation
acceptable salts
Prior art date
Application number
DK434488A
Other languages
English (en)
Other versions
DK170802B1 (da
DK434488A (da
Inventor
Ian Anthony Cliffe
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718444A external-priority patent/GB8718444D0/en
Priority claimed from GB888811975A external-priority patent/GB8811975D0/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK434488D0 publication Critical patent/DK434488D0/da
Publication of DK434488A publication Critical patent/DK434488A/da
Application granted granted Critical
Publication of DK170802B1 publication Critical patent/DK170802B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK434488A 1987-08-04 1988-08-03 Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem DK170802B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878718444A GB8718444D0 (en) 1987-08-04 1987-08-04 Ethers
GB8718444 1987-08-04
GB8811975 1988-05-20
GB888811975A GB8811975D0 (en) 1988-05-20 1988-05-20 Ethers

Publications (3)

Publication Number Publication Date
DK434488D0 true DK434488D0 (da) 1988-08-03
DK434488A DK434488A (da) 1989-02-05
DK170802B1 DK170802B1 (da) 1996-01-22

Family

ID=26292571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434488A DK170802B1 (da) 1987-08-04 1988-08-03 Azabicycliske ethere og farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og far maceutiske præparater indeholdende dem

Country Status (15)

Country Link
US (3) US4929625A (da)
EP (1) EP0306148B1 (da)
JP (1) JP2711272B2 (da)
KR (1) KR970002635B1 (da)
AU (1) AU605896B2 (da)
CA (1) CA1307790C (da)
DE (1) DE3887039T2 (da)
DK (1) DK170802B1 (da)
ES (1) ES2061660T3 (da)
FI (1) FI94250C (da)
GB (1) GB2208510B (da)
HU (1) HU203348B (da)
IE (1) IE61026B1 (da)
IL (1) IL87329A (da)
PT (1) PT88177B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
PT97637B (pt) * 1990-05-11 1998-08-31 Sankyo Co Processo para a preparacao de derivados piperidiloxi- e quinuclidiniloxi-isoxazolicos e de composicoes farmaceuticas que os contem
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
GB9019973D0 (en) * 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azabicyclic derivatives
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5948793A (en) * 1992-10-09 1999-09-07 Abbott Laboratories 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5512574A (en) * 1994-12-21 1996-04-30 American Home Products Corporation Quinuclidine and azabicyclo 2.2.1! heptane pyrazinyl ethers as muscarinic agonists
EP0773027A1 (en) * 1995-11-13 1997-05-14 Eli Lilly And Company Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety
EP0874828A4 (en) * 1995-12-06 1999-09-01 Lilly Co Eli PAIN TREATMENT COMPOSITIONS
US6133253A (en) * 1996-12-10 2000-10-17 Abbott Laboratories 3-Pyridyl enantiomers and their use as analgesics
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US20030147697A1 (en) * 2002-02-06 2003-08-07 Brady Patrick Richard Evaporative desorption soil treatment apparatus and process
ATE384720T1 (de) * 2002-08-14 2008-02-15 Neurosearch As Chinucledin - derivate und deren verwendung
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
US7418763B2 (en) * 2003-02-26 2008-09-02 Black & Decker Inc. Hand vacuum with filter indicator
KR20060030482A (ko) * 2003-06-24 2006-04-10 뉴로서치 에이/에스 신규한 8-아자-바이사이클로[3.2.1]옥탄 유도체 및모노아민 신경전달물질 재흡수 억제제로서의 이의 용도
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
NZ573735A (en) * 2006-05-19 2011-10-28 Abbott Lab Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2640829A (en) * 1950-11-10 1953-06-02 Smith Kline French Lab Isoquinolyl heterocyclic ethers
NL7109301A (da) * 1970-07-15 1972-01-18
US4261990A (en) * 1979-03-09 1981-04-14 Ciba-Geigy Corporation N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
GB8302483D0 (en) * 1983-01-29 1983-03-02 Beecham Group Plc Compounds
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group p.l.c., Brentford, Middlesex Arzneimittel zur behandlung von erbrechen.
DE3788057T2 (de) * 1986-12-17 1994-03-03 Glaxo Group Ltd Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
GB8718445D0 (en) * 1987-08-04 1987-09-09 Wyeth John & Brother Ltd Pyridyl-ethers
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
DE3839385A1 (de) * 1988-11-22 1990-05-23 Boehringer Ingelheim Kg Neue quinuclidine, ihre herstellung als arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US5082843A (en) 1992-01-21
ES2061660T3 (es) 1994-12-16
US4929625A (en) 1990-05-29
DE3887039T2 (de) 1994-04-28
EP0306148A3 (en) 1990-05-23
FI94250C (fi) 1995-08-10
AU2035988A (en) 1989-02-09
HUT48247A (en) 1989-05-29
FI883632A (fi) 1989-02-05
CA1307790C (en) 1992-09-22
EP0306148B1 (en) 1994-01-12
FI883632A0 (fi) 1988-08-03
HU203348B (en) 1991-07-29
GB2208510A (en) 1989-04-05
JP2711272B2 (ja) 1998-02-10
IL87329A0 (en) 1989-01-31
US4997839A (en) 1991-03-05
PT88177B (pt) 1995-03-01
KR970002635B1 (ko) 1997-03-07
GB8818323D0 (en) 1988-09-07
IL87329A (en) 1992-12-01
GB2208510B (en) 1991-03-06
KR890003753A (ko) 1989-04-17
EP0306148A2 (en) 1989-03-08
AU605896B2 (en) 1991-01-24
DK170802B1 (da) 1996-01-22
DE3887039D1 (de) 1994-02-24
IE882375L (en) 1989-02-04
PT88177A (pt) 1989-06-30
DK434488A (da) 1989-02-05
JPH0193585A (ja) 1989-04-12
IE61026B1 (en) 1994-09-07
FI94250B (fi) 1995-04-28

Similar Documents

Publication Publication Date Title
DK434488D0 (da) Heteroarylethere og heteroaromatiske n-oxider eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK208787A (da) Quinolinderivater og farmaceutisk acceptable estere deraf, deres farmaceutisk acceptable salte samt fremstilling og anvendelse deraf
DK203985A (da) Pyrimidinderivater, deres fremstilling og farmaceutiske anvendelse
DK519189D0 (da) Spiro-isoquinolin-pyrrolidin-tetroner eller farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489A (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
DK461389D0 (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK69389A (da) Renin-haemmende aminosyrederivater og fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK278188D0 (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK573788A (da) Quinolinderivater eller farmaceutiske acceptable estere eller salte deraf, deres fremstilling og anvendelse
DK73287D0 (da) Insulinderivater, deres fremstilling og anvendelse
DK543788D0 (da) Reninhaemmende dipeptider eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK157387A (da) Substiturede 4-amino-3-hydroxysmoersyrederivater ogfysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK223288D0 (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK412188A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK404386D0 (da) Spergualinbeslaegtede forbindelser eller fysiologisk acceptable salte deraf, deres fremstilling og anvendelse
DK530388D0 (da) Pyrrolo-(1,2-b)cinnoliner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK72887A (da) 2-aminoacyloxymethyl-2-penem-forbindelser og salte deraf samt deres fremstilling og anvendelse
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK361388D0 (da) Cephemderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK